表紙：サブオキソンの世界市場 - 種類別・剤形別・流通チャネル別・地域別：市場規模・シェア・将来展望・機会分析 (2022年～2030年)

市場調査レポート

商品コード

1073637

サブオキソンの世界市場 - 種類別・剤形別・流通チャネル別・地域別：市場規模・シェア・将来展望・機会分析 (2022年～2030年)

Suboxone Market, by Type, by Formulation, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

出版日: 2022年04月11日 | 発行: Coherent Market Insights

| ページ情報: 英文 185 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF (Single User License)

USD 4,500 704,385円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は一度のみ可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Multi User License)

USD 7,000 1,095,710円

レポートPDFを7名までにてご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は7回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise User License)

USD 10,000 1,565,300円

レポートPDFを同一企業およびその子会社のすべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.53円

全表示
概要
目次

概要

サンプル依頼リストに入れる

サブオキソン (Suboxone) は処方オピオイド薬の一種で、オピオイド依存症を引き起こす可能性のある薬剤 (鎮痛剤など) の効果を抑制するために使用されます。市場の主な促進要因として、製品上市の動きの拡大や、慢性疼痛の有病率の上昇などが挙げられます。

当レポートでは、世界のサブオキソンの市場について分析し、製品の概要や、市場の基本構造および促進・抑制要因、新型コロナウイルス感染症 (COVID-19) の影響、種類別・剤形別・流通チャネル別・地域別の市場動向の見通し、主要企業のプロファイル・業績・戦略などを調査しております。

Indivior PLC.
- 企業概要
- 製品ポートフォリオ
- 昨今の主な動向
- 財務実績
- 市場戦略
Dr. Reddy's Laboratories Ltd.
Amneal Pharmaceuticals LLC.
Mylan N.V.
Novartis AG
Teva Pharmaceutical Industries Ltd.
Mallinckrodt
Lannett Co Inc.
Rhodes Pharmaceuticals L.P.
Alvogen
Sun Pharmaceutical Industries Ltd.
Alkem Labs
Hikma Pharmaceuticals PLC

第10章付録

Product Code: CMI5000

Suboxone is a prescription opioid medication that is used to inhibit the effects of opioid medications, such as pain relief, which can lead to opioid dependence. Suboxone can be used alone or in combination with other drugs to treat opioid addiction. Suboxone belongs to a drug class known as opioid antagonists, analgesics, and opioid partial agonists. Suboxone is composed of buprenorphine and naloxone. Buprenorphine is an opioid medicine, sometimes known as a narcotic. Naloxone counteracts the benefits of opioid medications, such as pain relief and feelings of well-being, which can lead to opioid dependence.

Market Dynamics

The increasing product launches for suboxone is expected to drive the growth of global suboxone market over the forecast period. In September 2018, Lannett Co Inc., a global manufacturer of pharmaceutical products, launched five products that include Buprenorphine plus Naloxone Sublingual tablets, and others.

Moreover, increasing prescription of opioids in certain regions is expected to drive the market growth over the forecast period. For instance, a research published by EclinicalMedicine, a new open access clinical journal, in November 2021 stated that the U.K. had the highest consumption rate of prescription opioids for pain management per capita in the world, despite declining rates globally.

Furthermore, increasing prevalence of chronic pain is expected to drive the growth of global suboxone market over the forecast period. For instance, according to data published by Centers for Disease Control and Prevention in September 2018, stated that an estimated 20.4% of the U.S. adults (50.0 million) had chronic pain and 8.0% of the U.S. adults (19.6 million) had high-impact chronic pain with higher prevalence associated with advancing age in 2016.

Key features of the study:

This report provides an in-depth analysis of the global suboxone market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global suboxone market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Indivior PLC, Dr. Reddy's Laboratories Ltd., Amneal Pharmaceuticals LLC., Mylan N.V., Novartis AG, Teva Pharmaceutical Industries Ltd., Mallinckrodt, Lannett Co Inc., Rhodes Pharmaceuticals L.P., Alvogen, Sun Pharmaceutical Industries Ltd., Alkem Labs, and Hikma Pharmaceuticals PLC
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global suboxone market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global suboxone market

Detailed Segmentation:

Global Suboxone Market, By Type:
- Branded
- Generics
Global Suboxone Market, By Formulation:
- Tablets
- Films
Global Suboxone Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Suboxone Market, By Region:
- North America
  - By Type
  - Branded
  - Generics
  - By Formulation
  - Tablets
  - Films
  - By Distribution Channel
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
  - By Country
  - U.S.
  - Canada
- Latin America
  - By Type
  - Branded
  - Generics
  - By Formulation
  - Tablets
  - Films
  - By Distribution Channel
  - Hospital Pharmacies
  - Retail Pharmacies
  - By Country
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
- Europe
  - By Type
  - Branded
  - Generics
  - By Formulation
  - Tablets
  - Films
  - By Distribution Channel
  - Hospital Pharmacies
  - Retail Pharmacies
  - By Country
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
- Asia Pacific
  - By Type
  - Branded
  - Generics
  - By Formulation
  - Tablets
  - Films
  - By Distribution Channel
  - Hospital Pharmacies
  - Retail Pharmacies
  - By Country
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
- Middle East
  - By Type
  - Branded
  - Generics
  - By Formulation
  - Tablets
  - Films
  - By Distribution Channel
  - Hospital Pharmacies
  - Retail Pharmacies
  - By Country
  - GCC
  - Israel
  - Rest of Middle East
- Africa
  - By Type
  - Branded
  - Generics
  - By Formulation
  - Tablets
  - Films
  - By Distribution Channel
  - Hospital Pharmacies
  - Retail Pharmacies
  - By Region/Country
  - South Africa
  - Central Africa
  - North Africa
Company Profiles
- Indivior PLC.
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Dr. Reddy's Laboratories Ltd.
- Amneal Pharmaceuticals LLC.
- Mylan N.V.
- Novartis AG
- Teva Pharmaceutical Industries Ltd.
- Mallinckrodt
- Lannett Co Inc.
- Rhodes Pharmaceuticals L.P.
- Alvogen
- Sun Pharmaceutical Industries Ltd.
- Alkem Labs
- Hikma Pharmaceuticals PLC

"*" marked represents similar segmentation in other categories in the respective section

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Formulation
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
New Product Launches
Regulatory Scenario
PEST Analysis
PORTER's Analysis
Key Developments
Brand Analysis
Strategic Agreement, Merger And Acquisitions

4. Global Suboxone Market- COVID-19 Impact Analysis

Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand

5. Global Suboxone Market, By Type, 2017 - 2030, (US$ Million)

Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Branded
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Generics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Suboxone Market, By Formulation, 2017 - 2030, (US$ Million)

Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Tablets
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Films
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Suboxone Market, By Distribution Channel, 2017 - 2030, (US$ Million)

Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Hospital pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

8. Global Suboxone Market, By Region, 2017 - 2030, (US$ Million)

Introduction
- Market Share Analysis, By Region, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2018-2030
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
- U.S.
- Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
- UK
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
- GCC
- Israel
- Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
- North Africa
- Central Africa
- South Africa

9. Competitive Landscape

Indivior PLC.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Dr. Reddy's Laboratories Ltd.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Amneal Pharmaceuticals LLC.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Mylan N.V.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Novartis AG
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Teva Pharmaceutical Industries Ltd.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Mallinckrodt
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Lannett Co Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Rhodes Pharmaceuticals L.P.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Alvogen
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Sun Pharmaceutical Industries Ltd.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Alkem Labs
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Hikma Pharmaceuticals PLC
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies

10. Section

Research Methodology
About Us

サブオキソンの世界市場 - 種類別・剤形別・流通チャネル別・地域別：市場規模・シェア・将来展望・機会分析 (2022年～2030年)

Suboxone Market, by Type, by Formulation, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

目次

第1章分析目的・前提条件

第2章市場概略

第3章市場の力学・規制・動向の分析

第4章世界のスボクソン市場：新型コロナウイルス感染症 (COVID-19) の影響分析

第5章世界のサブオキソン市場：種類別 (単位：100万米ドル、2017年～2030年)

第6章世界のサブオキソン市場：剤形別 (単位：100万米ドル、2017年～2030年)

第7章世界のサブオキソン市場：流通チャネル別 (単位：100万米ドル、2017年～2030年)

第8章世界のサブオキソン市場：地域別 (単位：100万米ドル、2017年～2030年)

第9章競合情勢

第10章付録

Market Dynamics

Key features of the study:

Detailed Segmentation:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Suboxone Market- COVID-19 Impact Analysis

5. Global Suboxone Market, By Type, 2017 - 2030, (US$ Million)

6. Global Suboxone Market, By Formulation, 2017 - 2030, (US$ Million)

7. Global Suboxone Market, By Distribution Channel, 2017 - 2030, (US$ Million)

8. Global Suboxone Market, By Region, 2017 - 2030, (US$ Million)

9. Competitive Landscape

10. Section

サブオキソンの世界市場 - 種類別・剤形別・流通チャネル別・地域別：市場規模・シェア・将来展望・機会分析 (2022年～2030年)

Suboxone Market, by Type, by Formulation, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

目次

第1章 分析目的・前提条件

第2章 市場概略

第3章 市場の力学・規制・動向の分析

第4章 世界のスボクソン市場：新型コロナウイルス感染症 (COVID-19) の影響分析

第5章 世界のサブオキソン市場：種類別 (単位：100万米ドル、2017年～2030年)

第6章 世界のサブオキソン市場：剤形別 (単位：100万米ドル、2017年～2030年)

第7章 世界のサブオキソン市場：流通チャネル別 (単位：100万米ドル、2017年～2030年)

第8章 世界のサブオキソン市場：地域別 (単位：100万米ドル、2017年～2030年)

第9章 競合情勢

第10章 付録

Market Dynamics

Key features of the study:

Detailed Segmentation:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Suboxone Market- COVID-19 Impact Analysis

5. Global Suboxone Market, By Type, 2017 - 2030, (US$ Million)

6. Global Suboxone Market, By Formulation, 2017 - 2030, (US$ Million)

7. Global Suboxone Market, By Distribution Channel, 2017 - 2030, (US$ Million)

8. Global Suboxone Market, By Region, 2017 - 2030, (US$ Million)

9. Competitive Landscape

10. Section

第1章分析目的・前提条件

第2章市場概略

第3章市場の力学・規制・動向の分析

第4章世界のスボクソン市場：新型コロナウイルス感染症 (COVID-19) の影響分析

第5章世界のサブオキソン市場：種類別 (単位：100万米ドル、2017年～2030年)

第6章世界のサブオキソン市場：剤形別 (単位：100万米ドル、2017年～2030年)

第7章世界のサブオキソン市場：流通チャネル別 (単位：100万米ドル、2017年～2030年)

第8章世界のサブオキソン市場：地域別 (単位：100万米ドル、2017年～2030年)

第9章競合情勢

第10章付録